vs
Allot Ltd.（ALLT）与Assertio Holdings, Inc.（ASRT）财务数据对比。点击上方公司名可切换其他公司
Allot Ltd.的季度营收约是Assertio Holdings, Inc.的1.8倍（$24.1M vs $13.5M），Allot Ltd.同比增速更快（8.5% vs -57.9%）
Allot Ltd.是一家以色列高科技企业，前身为Allot Communications，核心业务为电信软件开发，公司总部设于以色列霍德哈沙伦，在通信技术软件领域拥有深厚的技术积累。
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
ALLT vs ASRT — 直观对比
营收规模更大
ALLT
是对方的1.8倍
$13.5M
营收增速更快
ALLT
高出66.4%
-57.9%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.1M | $13.5M |
| 净利润 | $-1.7M | — |
| 毛利率 | 72.1% | — |
| 营业利润率 | -1.7% | -86.7% |
| 净利率 | -7.0% | — |
| 营收同比 | 8.5% | -57.9% |
| 净利润同比 | 49.6% | — |
| 每股收益（稀释后） | $-0.04 | $-4.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLTASRT
| Q4 25 | — | $13.5M | ||
| Q3 25 | — | $49.5M | ||
| Q2 25 | $24.1M | $29.2M | ||
| Q1 25 | $23.1M | $26.5M | ||
| Q4 24 | — | $32.2M | ||
| Q3 24 | — | $29.2M | ||
| Q2 24 | $22.2M | $31.1M | ||
| Q1 24 | — | $32.4M |
净利润ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | $-1.7M | $-16.4M | ||
| Q1 25 | $-332.0K | $-13.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-2.9M | ||
| Q2 24 | $-3.4M | $-3.7M | ||
| Q1 24 | — | $-4.5M |
毛利率ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 69.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | — | — |
营业利润率ALLTASRT
| Q4 25 | — | -86.7% | ||
| Q3 25 | — | 23.2% | ||
| Q2 25 | -1.7% | -27.5% | ||
| Q1 25 | -3.1% | -50.0% | ||
| Q4 24 | — | -41.9% | ||
| Q3 24 | — | -10.4% | ||
| Q2 24 | -15.2% | -11.6% | ||
| Q1 24 | — | -13.4% |
净利率ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | 23.1% | ||
| Q2 25 | -7.0% | -56.0% | ||
| Q1 25 | -1.4% | -51.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -10.0% | ||
| Q2 24 | -15.1% | -11.8% | ||
| Q1 24 | — | -13.9% |
每股收益（稀释后）ALLTASRT
| Q4 25 | — | $-4.54 | ||
| Q3 25 | — | $0.11 | ||
| Q2 25 | $-0.04 | $-0.17 | ||
| Q1 25 | $-0.01 | $-0.14 | ||
| Q4 24 | — | $-3.28 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | $-0.09 | $-0.04 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.1M | $63.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $99.7M | $94.0M |
| 总资产 | $154.1M | $267.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALLTASRT
| Q4 25 | — | $63.4M | ||
| Q3 25 | — | $93.4M | ||
| Q2 25 | $60.1M | $98.2M | ||
| Q1 25 | $10.1M | $87.3M | ||
| Q4 24 | — | $100.1M | ||
| Q3 24 | — | $88.6M | ||
| Q2 24 | $15.9M | $88.4M | ||
| Q1 24 | — | $80.7M |
总债务ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $38.6M |
股东权益ALLTASRT
| Q4 25 | — | $94.0M | ||
| Q3 25 | — | $105.8M | ||
| Q2 25 | $99.7M | $93.3M | ||
| Q1 25 | $50.0M | $108.5M | ||
| Q4 24 | — | $121.1M | ||
| Q3 24 | — | $130.5M | ||
| Q2 24 | $46.7M | $132.2M | ||
| Q1 24 | — | $134.5M |
总资产ALLTASRT
| Q4 25 | — | $267.0M | ||
| Q3 25 | — | $319.8M | ||
| Q2 25 | $154.1M | $273.8M | ||
| Q1 25 | $140.3M | $286.4M | ||
| Q4 24 | — | $284.7M | ||
| Q3 24 | — | $276.0M | ||
| Q2 24 | $132.5M | $279.4M | ||
| Q1 24 | — | $282.0M |
负债/权益比ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4M | $-30.0M |
| 自由现金流经营现金流 - 资本支出 | $4.0M | — |
| 自由现金流率自由现金流/营收 | 16.5% | — |
| 资本支出强度资本支出/营收 | 1.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-6.0M | — |
8季度趋势，按日历期对齐
经营现金流ALLTASRT
| Q4 25 | — | $-30.0M | ||
| Q3 25 | — | $-4.8M | ||
| Q2 25 | $4.4M | $19.1M | ||
| Q1 25 | $1.7M | $-12.5M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $-35.0K | ||
| Q2 24 | $1.2M | $7.4M | ||
| Q1 24 | — | $7.5M |
自由现金流ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $4.0M | — | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $217.0K | — | ||
| Q1 24 | — | — |
自由现金流率ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | — | — |
资本支出强度ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | — | — |
现金转化率ALLTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | -0.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALLT
暂无分部数据
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
